Dr. Amro Elshoury, MD

Dr. Elshoury practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Elshoury's NPI, 1417398975, was assigned on July 12, 2013. Dr. Elshoury holds Indiana license 01092534A.

Dr. Elshoury's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Elshoury's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Elshoury is also affiliated with Ascension St. Vincent Hospital - Indianapolis. The medical group on file is Innovative Hematology / Indiana Hemophilia & Thrombosis Center. Dmand AI also links Dr. Elshoury to 2 more group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Elshoury practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Elshoury's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Elshoury's licenses on file in 2 states: Indiana and New York.

CMS data shows 32 Medicare services from Dr. Elshoury across 1 procedure code in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $3,479 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Elshoury in 2024. The largest group is 75 to 84, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Elshoury's median patient age at 51, with 60% women.

In 2024, Dr. Elshoury wrote 38 Medicare Part D claims for 27 patients. 66% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $193,869 in total drug cost. In 2020, CMS named 46 claims across 3 drugs.

Dr. Elshoury accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Elshoury as offering telehealth.

Dmand AI links 13 papers to Dr. Elshoury, published from 2015 to 2023. 2022 was the busiest year, with 4. The most frequent topics are Venous Thromboembolism, Anticoagulants and Myeloproliferative Disorders. Dr. Elshoury has published most often in J Natl Compr Canc Netw. Dr. Elshoury's most frequent co-authors are Jason Gotlib, MD, MS, Krishna Gundabolu, MD and Elizabeth O. Hexner, MD.

Dmand AI links Dr. Elshoury to 1 clinical trial. Conditions studied include Leukemia, Mast-Cell and Mastocytosis, Systemic.

CMS Open Payments shows 213 general payments to Dr. Elshoury from 9 drug and device companies from 2020 to 2025. Honoraria make up the largest share, 86% of the total. Blueprint Medicines Corporation paid the most, $209,105.